ProcessClaims Captures E-Fusion Award
California-based ProcessClaims, a provider of software connectivity and business process automation solutions for the Property and Casualty claims industry, accepted the E-Fusion award in the Office Automation Management category at the 2004 A.M. Best Co. Insurance and Technology Conference in Baltimore recently. The award recognizes innovation in insurance technology.
David Ferrara, EVP and co-founder, said that this award is especially gratifying for two reasons, “Being judged by one’s peers is always very satisfying. The judges are from carriers and vendors that really understand the importance of process improvement. Secondly, A.M. Best provides enormous credibility to an area of claims operations that has historically received little attention. We appreciate the recognition from these groups and view it as validation of our vision.”
The awards judges included Michael Edwards, chief information officer, American Skyline Insurance Co.; Robert Litt, partner, KPMG LLP Information Risk Management; Thomas Meyers, senior vice president and chief financial officer, New Jersey Manufacturers Insurance Co.; In addition, the A.M. Best Co. executives who participated in the judging were Paul Tinnirello, executive vice president and E-Fusion conference chairman.
ProcessClaims was also recently named in Deloitte’s Technology Fast 50 Rising Star and a finalist for Software Company of the Year by the Southern California Software Association.
- OpenAI Floats Idea of Global AI Governance Body With US, China
- California Fire Spread Slows But Dangerous Conditions Linger
- Verisk Report Shows Drop in US Reconstruction Costs in 2Q
- ‘Big Tobacco’ Moment for Cannabis: What Insurers Need to Know About Murray v. Cresco
- AI Ruling Prompts Warnings From Lawyers: Your Chats Could Be Used Against You
- Florida Woman Drives Elevated Pickup Over Lamborghini Sports Car in Parking Lot
- The Adjuster’s Year Ahead: What AI Will and Won’t Change About the Job
- A 16,000% Problem: Why Workers’ Comp Can’t Get Drug Costs Under Control